1-5 of 5
Bhavjot Bindra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Paulina B. Lange, Bhavjot Bindra, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Brett Glotzbecker, MD, Jerome Ritz, MD, Bruce R Blazar, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, MD
Journal: Blood
Blood (2013) 122 (21): 3335.
https://doi.org/10.1182/blood.V122.21.3335.3335
Published: 2013
Journal Articles

A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease

Alex F. Herrera, MD, Haesook T. Kim, PhD, Bhavjot Bindra, Edwin P. Alyea, MD, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, John Koreth, MBBS, DPhil
Journal: Blood
Blood (2013) 122 (21): 909.
https://doi.org/10.1182/blood.V122.21.909.909
Published: 2013
Journal Articles

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial

Corey Cutler, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, Sean McDonough, Phandee Watanaboonyongcharoen, Philippe Armand, John Koreth, Brett Glotzbecker, Edwin Alyea, Bruce R. Blazar, Robert J. Soiffer, Jerome Ritz, Joseph H. Antin
Journal: Blood
Blood (2013) 122 (8): 1510–1517.
https://doi.org/10.1182/blood-2013-04-495895
Published: 2013
Journal Articles

A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease

Sarah Nikiforow, MD, PhD, Haesook T Kim, PhD, Bhavjot Bindra, Sean McDonough, MS, Brett Glotzbecker, MD, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Vincent T Ho, MD, Edwin P Alyea, III, MD, Jerome Ritz, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD, MPH, FRCPC
Journal: Blood
Blood (2012) 120 (21): 744.
https://doi.org/10.1182/blood.V120.21.744.744
Published: 2012
Journal Articles

Prophylactic Rituximab After Allogeneic Stem Cell Transplantation Prevents Steroid-Requiring Chronic Graft-Vs.Host Disease

Corey Cutler, MD, MPH, FRCPC, Lixian Sun, MS, Haesook Kim, PhD, Stefanie Sarantopoulos, MD, PhD, Bhavjot Bindra, Yi-Bin Chen, MD, Jacalyn Rosenblatt, MD, MSc, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Vincent T. Ho, MD, Edwin P. Alyea, III, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Joseph H. Antin, MD
Journal: Blood
Blood (2010) 116 (21): 214.
https://doi.org/10.1182/blood.V116.21.214.214
Published: 2010